Literature DB >> 19962862

Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia.

Nienke Dekker1, Nicole Schmitz, Bart D Peters, Therese A van Amelsvoort, Don H Linszen, Lieuwe de Haan.   

Abstract

Adolescent-onset cannabis use, compared with adult-onset use, has been associated with a higher risk for developing symptoms of schizophrenia-like psychotic disorders. To test the hypothesis that onset of cannabis use in early adolescence in male schizophrenia patients is associated with abnormalities in white matter structure and integrity, we used high resolution structural and diffusion tensor brain images to compare three groups of patients: those who started regular use of cannabis (1) before the age of 15 years (early-onset cannabis users, n = 10) or (2) at the age of 17 years or later (late-onset cannabis users, n = 8), and (3) those who were cannabis naïve (n = 8). To verify patient findings, we also compared white matter integrity of the three patient groups with that of a healthy control group (n = 10). Cannabis naïve patients showed reduced white matter density and reduced fractional anisotropy, an indicator for white matter integrity, in the splenium of the corpus callosum compared with patients with early-onset cannabis use. In the same brain area, cannabis naïve patients showed reduced fractional anisotropy compared with healthy controls. Our results suggest that the age of onset of cannabis use is not an identifying characteristic for white matter abnormalities in schizophrenia patients; however, our results might indicate a more vulnerable brain structure in cannabis naïve schizophrenia patients.

Entities:  

Mesh:

Year:  2010        PMID: 19962862     DOI: 10.1016/j.pscychresns.2009.06.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  22 in total

1.  Diffusion abnormalities in the corpus callosum in first episode schizophrenia: Associated with enlarged lateral ventricles and symptomatology.

Authors:  Elisabetta C Del Re; Sylvain Bouix; Jennifer Fitzsimmons; Gabriëlla A M Blokland; Raquelle Mesholam-Gately; Joanne Wojcik; Zora Kikinis; Marek Kubicki; Tracey Petryshen; Ofer Pasternak; Martha E Shenton; Margaret Niznikiewicz
Journal:  Psychiatry Res       Date:  2019-02-18       Impact factor: 3.222

2.  Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?

Authors:  Jasmina Mallet; Nicolas Ramoz; Yann Le Strat; Philip Gorwood; Caroline Dubertret
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-02-11       Impact factor: 5.270

Review 3.  Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.

Authors:  Kaloyan Rumenov Stoychev
Journal:  Front Psychiatry       Date:  2019-10-23       Impact factor: 4.157

4.  Effects of eye dominance (left vs. right) and cannabis use on intermanual coordination and negative symptoms in schizophrenia patients.

Authors:  Inge Gorynia; Markus Schwaiger; Andreas Heinz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-05-04       Impact factor: 5.270

5.  Pathology of white matter integrity in three major white matter fasciculi: A post-mortem study of schizophrenia and treatment status.

Authors:  Kirsten E Schoonover; Charlene B Farmer; Andrew E Cash; Rosalinda C Roberts
Journal:  Br J Pharmacol       Date:  2019-03-18       Impact factor: 8.739

6.  Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis.

Authors:  Lisa Buchy; Larry J Seidman; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; William Stone; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Jean Addington
Journal:  Psychiatry Res       Date:  2015-11-25       Impact factor: 3.222

7.  Patterns of brain structural changes in first-contact, antipsychotic drug-naive patients with schizophrenia.

Authors:  M Filippi; E Canu; R Gasparotti; F Agosta; P Valsecchi; G Lodoli; A Galluzzo; G Comi; E Sacchetti
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-06       Impact factor: 3.825

8.  MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.

Authors:  O E Onwuameze; K W Nam; E A Epping; T H Wassink; S Ziebell; N C Andreasen; B-C Ho
Journal:  Psychol Med       Date:  2012-07-31       Impact factor: 7.723

9.  Markers of copper transport in the cingulum bundle in schizophrenia.

Authors:  Kirsten E Schoonover; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2021-01-09       Impact factor: 4.939

10.  An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.

Authors:  Else-Marie Løberg; Merethe Nygård; Jan Øystein Berle; Erik Johnsen; Rune A Kroken; Hugo A Jørgensen; Kenneth Hugdahl
Journal:  Front Psychiatry       Date:  2012-10-30       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.